The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Vulvovaginitis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Vulvovaginitis

 

High impact information on Vulvovaginitis

  • Prepubertal gonococcal vulvovaginitis: a penicillin-resistant infection treated with cefotaxime [6].
  • The ABO, P1, and Lewis group phenotypes of 35 women with recurrent vulvovaginitis but without other chronic infections were determined [7].
  • Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles [8].
  • Severe vulvovaginitis associated with intravaginal nystatin therapy [9].
  • CONCLUSION: The expression of heat shock proteins and IL-10 in the vaginas of women with a history of recurrent vulvovaginitis but not in the vaginas of control subjects suggests the existence of differences in the vaginal milieu between the 2 groups, even when both are without vaginal symptoms [10].
 

Chemical compound and disease context of Vulvovaginitis

 

Gene context of Vulvovaginitis

  • The expression of the 60-kD and 70-kD heat shock proteins (hsp60 and hsp70) in the vaginas of 43 asymptomatic women of reproductive age with or without a history of recurrent vulvovaginitis (RVV) were compared [16].
  • The rates of C albicans colonization and vulvovaginitis among immunocompetent (CD4 count at least 500 cells/mm3) HIV-positive women did not differ from those among HIV-negative women [17].
  • Sixty per cent of animals developed vulvovaginitis, perigenital alopecia and hind-limb paresia [18].
  • Bovine herpesvirus type 1 (BoHV-1) is the causative agent of respiratory and genital tract infections such as infectious rhinotracheitis (IBR), infectious pustular vulvovaginitis (IPV, balanoposthitis (IBP), and abortion [19].
  • Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women [20].
 

Analytical, diagnostic and therapeutic context of Vulvovaginitis

References

  1. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study. Hansen, R.M., Reinerio, N., Sohnle, P.G., Abrams, R.A., Ritch, P.S., Libnoch, J.A., Anderson, T. Arch. Intern. Med. (1987) [Pubmed]
  2. Sexually transmitted diseases, HIV, and AIDS in women. Cohn, S.E., Clark, R.A. Med. Clin. North Am. (2003) [Pubmed]
  3. Incidence of pelvic inflammatory disease among women treated for gonorrhea or chlamydia. Rothman, K.J., Lanza, L., Lal, A., Peskin, E.G., Dreyer, N.A. Pharmacoepidemiology and drug safety. (1996) [Pubmed]
  4. An outbreak of vulvovaginitis in goats caused by a caprine herpesvirus. Horner, G.W., Hunter, R., Day, A.M. New Zealand veterinary journal. (1982) [Pubmed]
  5. Activity and tolerability of tetridamine vaginal lavage in rats and women. Manzardo, S., Girardello, R., Pinzetta, A., Coppi, G., De Aloysio, D. Bollettino chimico farmaceutico. (1992) [Pubmed]
  6. Prepubertal gonococcal vulvovaginitis: a penicillin-resistant infection treated with cefotaxime. Reynolds, V., Oates, J.K., Newsom, S.W. Lancet (1979) [Pubmed]
  7. Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. Hilton, E., Chandrasekaran, V., Rindos, P., Isenberg, H.D. J. Infect. Dis. (1995) [Pubmed]
  8. Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles. Dorrell, L., Edwards, A. Sexually transmitted infections. (2002) [Pubmed]
  9. Severe vulvovaginitis associated with intravaginal nystatin therapy. Dan, M. Am. J. Obstet. Gynecol. (2001) [Pubmed]
  10. Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis. Giraldo, P., Neuer, A., Korneeva, I.L., Ribeiro-Filho, A., Simões, J.A., Witkin, S.S. Am. J. Obstet. Gynecol. (1999) [Pubmed]
  11. Efficacy and tolerability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole. Loendersloot, E.W., Goormans, E., Wiesenhaan, P.E., Barthel, P.J., Branolte, J.H. Am. J. Obstet. Gynecol. (1985) [Pubmed]
  12. Symptoms associated with vaginal colonization with yeast. McCormack, W.M., Starko, K.M., Zinner, S.H. Am. J. Obstet. Gynecol. (1988) [Pubmed]
  13. Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Rigg, D., Miller, M.M., Metzger, W.J. Am. J. Obstet. Gynecol. (1990) [Pubmed]
  14. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. Fernández-Alba, J., Valle-Gay, A., Dibildox, M., Vargas, J.A., González, J., García, M., López, L.H. Journal of chemotherapy (Florence, Italy) (2004) [Pubmed]
  15. Systemic treatment of recurrent candidal vulvovaginitis by Itraconazole. Azzena, A., Vasoin, F. Clinical and experimental obstetrics & gynecology. (1994) [Pubmed]
  16. Detection of the human 70-kD and 60-kD heat shock proteins in the vagina: relation to microbial flora, vaginal pH, and method of contraception. Giraldo, P., Neuer, A., Ribeiro-Filho, A., Linhares, I., Witkin, S.S. Infectious diseases in obstetrics and gynecology. (1999) [Pubmed]
  17. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Duerr, A., Sierra, M.F., Feldman, J., Clarke, L.M., Ehrlich, I., DeHovitz, J. Obstetrics and gynecology. (1997) [Pubmed]
  18. Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2. Sanjuan, N.A., Lascano, E.F. Arch. Virol. (1986) [Pubmed]
  19. Pro and contra IBR-eradication. Ackermann, M., Engels, M. Vet. Microbiol. (2006) [Pubmed]
  20. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. Ozcan, S.K., Budak, F., Yucesoy, G., Susever, S., Willke, A. APMIS (2006) [Pubmed]
  21. Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. Kaufman, R.H., Henzl, M.R., Brown, D., Horner, D.S., Krauss, R.H., Mehlisch, D.R., Moore, D.E., Prentice, R.L. The Journal of reproductive medicine. (1989) [Pubmed]
  22. Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis. Weissenbacher, S., Witkin, S.S., Tolbert, V., Giraldo, P., Linhares, I., Haas, A., Weissenbacher, E.R., Ledger, W.J. Infectious diseases in obstetrics and gynecology. (2000) [Pubmed]
  23. Benzydamine for the topical treatment of vulvovaginitis in children and adolescents. Cisternino, M., Cammaresi, V., Cattaneo, E., Berbenni, A., Lorini, R., Severi, F. International journal of tissue reactions. (1985) [Pubmed]
 
WikiGenes - Universities